Shockwave Medical, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Shockwave Medical, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2018 to Q1 2024.
  • Shockwave Medical, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $22.9M, a 43.7% increase year-over-year.
  • Shockwave Medical, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $80.2M, a 56.2% increase year-over-year.
  • Shockwave Medical, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $73.2M, a 63.1% increase from 2022.
  • Shockwave Medical, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $44.9M, a 64.7% increase from 2021.
  • Shockwave Medical, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $27.3M, a 163% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $80.2M $22.9M +$6.97M +43.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $73.2M $21.8M +$9.17M +72.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 $64.1M $18.4M +$6.68M +56.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $57.4M $17M +$6.04M +54.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $51.3M $16M +$6.46M +67.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $44.9M $12.6M +$4.44M +54% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 $40.5M $11.7M +$4.35M +58.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $36.1M $11M +$4.48M +68.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $31.6M $9.51M +$4.37M +85.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $27.3M $8.21M +$5.03M +158% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 $22.2M $7.39M +$4.54M +160% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $17.7M $6.52M +$4.07M +166% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $13.6M $5.14M +$3.27M +175% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $10.4M $3.18M +$1.87M +143% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 $8.48M $2.85M +$1.74M +157% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $6.74M $2.45M +$1.63M +200% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $5.11M $1.87M +$1.46M +354% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $3.65M $1.31M +$892K +213% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 $2.75M $1.11M +$817K +283% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $1.94M $818K +$501K +158% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $1.44M $412K +$139K +50.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 $1.3M $418K Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $289K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $317K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $273K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.